6:14 p.m. July 24, 2025: An earlier version of this article said the name of the chief of maternal and fetal medicine at MetroWest Medical Center in Framingham, Mass., is Dr. David Urato. He is Dr.

In a year that saw advisory committees placed under a particularly bright microscope at the FDA, the agency held fewer ...

Majority of FDA advisory panel members found risks outweigh benefits. July 14, 2010 — -- The blockbuster diabetes drug Avandia is likely to be sold in a strikingly different way, even if the U.S.

An Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for menopause that critics say have discouraged women for decades from using ...

The U.S. Food and Drug Administration (FDA) announced today that it’s recommending the removal of black-box warnings, the agency’s highest warning for prescription medications, from all hormone ...

A Food and Drug Administration panel on Wednesday advocated for regulatory changes that would make testosterone medications more widely accessible, including removing their classification as ...

In a rare move, an advisory FDA panel voted 14-1 Oct. 19 in support of retracting Makena, the only treatment approved to help prevent preterm birth, from the market, which the agency fast-tracked and ...